Selvinaz Dalaklıoğlu
Impact in
- Geriatrics and Gerontology top 10%
- Sirtuins and Resveratrol in Medicine
- Pharmacology top 10%
- Drug-Induced Hepatotoxicity and Protection
Papers in
- Oncology 4
- PARP inhibition in cancer therapy 3
- Co-authors
- Arda Taşatargil (13 shared papers)Nurkan Aksoy (1 shared paper)Çiler Çelik-Özenci (7 shared papers)Gül Özbey (2 shared papers)Sadi S. Özdem (4 shared papers)Nazif Hikmet Aksoy (2 shared papers)Sebahat Özdem (2 shared papers)Nuray Erin (2 shared papers)
- Journals
- Peptides (2 papers)The Aging Male (1 paper)Pharmacological Research (1 paper)Vascular Pharmacology (1 paper)Pharmacognosy Magazine (1 paper)
- Partner nations
- Türkiye
In The Last Decade
Selvinaz Dalaklıoğlu
21 papers receiving 381 citations
Peers
Comparison fields: 5 of 76
- Geriatrics and Gerontology 22
- Pharmacology 47
- Pathology and Forensic Medicine 76
- Endocrine and Autonomic Systems 19
- Complementary and alternative medicine 20
Countries citing papers authored by Selvinaz Dalaklıoğlu
This map shows the geographic impact of Selvinaz Dalaklıoğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Selvinaz Dalaklıoğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Selvinaz Dalaklıoğlu more than expected).
Fields of papers citing papers by Selvinaz Dalaklıoğlu
This network shows the impact of papers produced by Selvinaz Dalaklıoğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Selvinaz Dalaklıoğlu. The network helps show where Selvinaz Dalaklıoğlu may publish in the future.
Co-authors
The 8 scholars most cited alongside Selvinaz Dalaklıoğlu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 107 | |
| 2 | 2017 | 46 | |
| 3 | 2009 | 30 | |
| 4 | 2005 | 22 | |
| 5 | 2012 | 19 | |
| 6 | 2004 | 19 | |
| 7 | 2014 | 17 | |
| 8 | 2008 | 17 | |
| 9 | 2013 | 15 | |
| 10 | 2013 | 14 | |
| 11 | 2013 | 12 | |
| 12 | 2005 | 12 | |
| 13 | 2013 | 10 | |
| 14 | 2013 | 10 | |
| 15 | 2018 | 10 | |
| 16 | 2016 | 10 | |
| 17 | 2006 | 8 | |
| 18 | 2013 | 3 | |
| 19 | 2016 | 3 | |
| 20 | 2016 | 3 |
About Selvinaz Dalaklıoğlu
Selvinaz Dalaklıoğlu is a scholar working on Cardiology and Cardiovascular Medicine, Oncology, Physiology, Pathology and Forensic Medicine and Psychiatry and Mental health, having authored 21 papers that have together received 388 indexed citations. Recurring topics across this work include Pain Mechanisms and Treatments (3 papers), PARP inhibition in cancer therapy (3 papers), Vitamin C and Antioxidants Research (2 papers), Aldose Reductase and Taurine (2 papers), Sexual function and dysfunction studies (2 papers), Sirtuins and Resveratrol in Medicine (2 papers), Acute Lymphoblastic Leukemia research (2 papers) and Cardiac Ischemia and Reperfusion (2 papers). The work is most often cited by research in Geriatrics and Gerontology (22 citations), Pharmacology (47 citations), Pathology and Forensic Medicine (76 citations), Endocrine and Autonomic Systems (19 citations) and Complementary and alternative medicine (20 citations). Selvinaz Dalaklıoğlu has collaborated with scholars based in Türkiye. Frequent co-authors include Arda Taşatargil, Nurkan Aksoy, Çiler Çelik-Özenci, Gül Özbey, Sadi S. Özdem, Nazif Hikmet Aksoy, Sebahat Özdem and Nuray Erin. Their work appears in journals such as Peptides, The Aging Male, Pharmacological Research, Vascular Pharmacology and Pharmacognosy Magazine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.